Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Mochida Pharmaceutical Co.,Ltd.. A complete text table follows the diagram.
Revenue rose 7.6% and operating profit 31.0% as newer medicines and healthcare brands outgrew declining long-listed products.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Pharmaceutical-related business | 1 | 51.1B | 92.9% of reported total |
| Healthcare business | 1 | 3.9B | 7.1% of reported total |
| Rounding in management disclosure | 1 | 1M | 0.0% of reported total |
| Revenue | 2 | 55.0B | Six-month revenue by the two business lines disclosed in management analysis |
| Operating profit | 3 | 5.0B | 9.0% operating margin |
| Operating costs & expenses | 3 | 50.0B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 5.2B | Reported pretax result |
| New-drug growth, R&D and portfolio income | 3 | 213M | New medicines and healthcare brands lifted operating profit while research investment and security gains shaped the final result |
| Net profit attributable to owners | 5 | 3.9B | Reported parent-company result |
| Tax, attribution & other | 5 | 1.3B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Pharmaceutical-related business | Revenue | 51.1B |
| Healthcare business | Revenue | 3.9B |
| Rounding in management disclosure | Revenue | 1M |
| Revenue | Operating profit | 5.0B |
| Revenue | Operating costs & expenses | 50.0B |
| Operating profit | Profit before tax | 5.0B |
| New-drug growth, R&D and portfolio income | Profit before tax | 213M |
| Profit before tax | Net profit attributable to owners | 3.9B |
| Profit before tax | Tax, attribution & other | 1.3B |